Bruce L. Daugherty, Ph.D., MBA
Executive Vice President, Research
Bruce Daugherty joined Tonix in April 2012 and currently serves as the Executive Vice President of Research. Dr. Daugherty has extensive experience in drug development and basic biomedical research. For much of his career, he was with Merck & Co., where he led multiple drug discovery programs in various therapeutic areas including inflammation, immunology, respiratory and cardiovascular diseases. Dr. Daugherty was an early pioneer in the humanization of monoclonal antibodies and played a key role in Merck’s chemokine biology program. Dr. Daugherty started his career as a molecular biologist at the Roche Institute of Molecular Biology. He has also worked extensively as a consultant, where he provided drug development expertise to universities and biotechnology companies seeking to further develop their molecules and to out-license their technology to large pharmaceutical companies.
Dr. Daugherty has authored more than 50 original research papers that have been published in leading scientific journals, and he is an inventor on five issued patents.
Dr. Daugherty earned his Ph.D. in Molecular Genetics from Rutgers University-Robert Wood Johnson Medical School, his M.S. in Zoology from Rutgers University, and his B.A. in Biology from Washington University in St. Louis. Additionally, Dr. Daugherty earned his MBA from Emory University’s Goizueta Business School, where he won the entrepreneur award. Dr. Daugherty is also an Eagle Scout.